Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

por Kanemaru, Ayumi, Shinriki, Satoru, Kai, Mimi, Tsurekawa, Kanae, Ozeki, Kazuya, Uchino, Shota, Suenaga, Naoki, Yonemaru, Kou, Miyake, Shunsuke, Masuda, Takeshi, Kariya, Ryusho, Okada, Seiji, Takeshita, Hisashi, Seki, Yuki, Yano, Hiromu, Komohara, Yoshihiro, Yoshida, Ryoji, Nakayama, Hideki, Li, Jian-Dong, Saito, Hideyuki, Jono, Hirofumi
Publicado 2022

Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis

por Yamana, Keisuke, Inoue, Junki, Yoshida, Ryoji, Sakata, Junki, Nakashima, Hikaru, Arita, Hidetaka, Kawaguchi, Sho, Gohara, Shunsuke, Nagao, Yuka, Takeshita, Hisashi, Maeshiro, Manabu, Liu, Rin, Matsuoka, Yuichiro, Hirayama, Masatoshi, Kawahara, Kenta, Nagata, Masashi, Hirosue, Akiyuki, Toya, Ryo, Murakami, Ryuji, Kuwahara, Yoshikazu, Fukumoto, Manabu, Nakayama, Hideki
Publicado 2021

An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma

por Gohara, Shunsuke, Shinohara, Kosuke, Yoshida, Ryoji, Kariya, Ryusho, Tazawa, Hiroshi, Hashimoto, Masashi, Inoue, Junki, Kubo, Ryuta, Nakashima, Hikaru, Arita, Hidetaka, Kawaguchi, Sho, Yamana, Keisuke, Nagao, Yuka, Iwamoto, Asuka, Sakata, Junki, Matsuoka, Yuichiro, Takeshita, Hisashi, Hirayama, Masatoshi, Kawahara, Kenta, Nagata, Masashi, Hirosue, Akiyuki, Kuwahara, Yoshikazu, Fukumoto, Manabu, Okada, Seiji, Urata, Yasuo, Fujiwara, Toshiyoshi, Nakayama, Hideki
Publicado 2022